Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, Z.
Right arrow Articles by Perris, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, Z.
Right arrow Articles by Perris, R.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 93 No. 4 (February 15), 1999: pp. 1221-1230

Cooperative Activity of 4beta 1 and 4beta 7 Integrins in Mediating Human B-Cell Lymphoma Adhesion and Chemotaxis on Fibronectin Through Recognition of Multiple Synergizing Binding Sites Within the Central Cell-Binding Domain

Zhinan Yin, Emiliana Giacomello, Elena Gabriele, Luciano Zardi, Shin-ichi Aota, Kenneth M. Yamada, Barbara Skerlavaji, Roberto Doliana, Alfonso Colombatti, and Roberto Perris

From the Division for Experimental Oncology 2, Centro di Riferimento Oncologico Aviano, Istituto Nazionale Centroeuropeo, Aviano, Italy; the Department of Evolutionary and Functional Biology, University of Parma, Parma, Italy; the Istituto Nazionale per la Ricerca sul Cancro, Centro di Biotecnologie Avanzate, Genova, Italy; the Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD; and the Dipartimento di Scienze e Tecnologie Biomediche, University of Udine, Udine, Italy.

We have quantitated the relative contributions of the constitutively active alpha 4beta 1 and alpha 4beta 7 integrins and the domains embodying their cognate binding sites in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin. By cooperating, the central cell-binding and IIICS carboxy-terminal domains were entirely responsible for the adhesion activity displayed by fibronectin, and their relative contribution to this process was estimated to be 30% versus 70%. Assessment of the leukocyte-substrate binding strength (ie, dynes/cell) indicated a 10-fold higher avidity of the cell-IIICS domain interaction. The two integrins interchangeably recognized both domains, but differed quantitatively in their participation in the adhesive event, as well as in domain preference. The use of 3Fn (according to the nomenclature proposed by Bork and Koonin [Curr Opin Struct Biol 6:366, 1996] for the type III fibronectin modules) module-specific antibodies and recombinant polypeptides showed that alpha 4 integrins recognized both the RGD sequence (3Fn10) and an apparently novel synergistic site located within the 3Fn8 module; even in this case, the integrins displayed a distinct binding site preference. Interleukin-1beta (IL-1beta )/IL-2-induced chemotaxis also involved cooperative function of the central cell-binding and IIICS domains, but the mechanisms regulating this phenomenon differed markedly from those controlling cell adhesion. First, the relative contribution of the individual domains was comparable, but neither of the individual domains promoted migration to the extent observed on intact fibronectin. Secondly, alpha 4beta 1 and alpha 4beta 7 integrins were both involved in the domain-binding necessary for initiation of migration, but the relative contribution of each receptor in the chemotactic process was less disparate than for initial cell adhesion. Thirdly, the mode by which chemotactic B-lymphoma movement was supported by the central cell-binding domain differed from that sustaining cell adhesion in that it involved independent recognition of either the 3Fn8 or the 3Fn9 module, which acted in synergy with the 3Fn10 module. Our data provide novel evidence concerning the relative importance of the constitutively active alpha 4beta 1 and alpha 4beta 7 integrins for the interaction of B-cell lymphoma cells with fibronectin, and they emphasize a multiple and diverse recognition of sites responsible for either anchorage or locomotion of tumor leukocytes on this matrix molecule.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. L. Gonzalez, W. El-Bjeirami, J. L. West, L. V. McIntire, and C. W. Smith
Transendothelial migration enhances integrin-dependent human neutrophil chemokinesis
J. Leukoc. Biol., March 1, 2007; 81(3): 686 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. G. Lo, T. T. Lu, and J. G. Cyster
Integrin-dependence of Lymphocyte Entry into the Splenic White Pulp
J. Exp. Med., February 3, 2003; 197(3): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Altroff, L. Choulier, and H. J. Mardon
Synergistic Activity of the Ninth and Tenth FIII Domains of Human Fibronectin Depends upon Structural Stability
J. Biol. Chem., January 3, 2003; 278(1): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Kobayashi, M. Yamaguchi, S. Kim, J. Morikawa, S. Ogawa, S. Ueno, E. Suh, E. Dougherty, I. Shmulevich, H. Shiku, et al.
Microarray Reveals Differences in Both Tumors and Vascular Specific Gene Expression in de Novo CD5+ and CD5- Diffuse Large B-Cell Lymphomas
Cancer Res., January 1, 2003; 63(1): 60 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Wright, A. Hidalgo, J. M. Rodriguez-Frade, S. F. Soriano, M. Mellado, M. Parmo-Cabanas, M. J. Briskin, and J. Teixido
The Chemokine Stromal Cell-Derived Factor-1{alpha} Modulates {alpha}4{beta}7 Integrin-Mediated Lymphocyte Adhesion to Mucosal Addressin Cell Adhesion Molecule-1 and Fibronectin
J. Immunol., May 15, 2002; 168(10): 5268 - 5277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Yin, C. Chen, S. J. Szabo, L. H. Glimcher, A. Ray, and J. Craft
T-Bet Expression and Failure of GATA-3 Cross-Regulation Lead to Default Production of IFN-{gamma} by {gamma}{delta} T Cells
J. Immunol., February 15, 2002; 168(4): 1566 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Spessotto, Z. Yin, G. Magro, R. Deutzmann, A. Chiu, A. Colombatti, and R. Perris
Laminin Isoforms 8 and 10 Are Primary Components of the Subendothelial Basement Membrane Promoting Interaction with Neoplastic Lymphocytes
Cancer Res., January 1, 2001; 61(1): 339 - 347.
[Abstract] [Full Text]


Home page
BloodHome page
L. Bogetto, E. Gabriele, R. Cariati, R. Dolcetti, P. Spessotto, C. Doglioni, M. Boiocchi, R. Perris, and A. Colombatti
Bidirectional induction of the cognate receptor-ligand alpha 4/VCAM-1 pair defines a novel mechanism of tumor intravasation
Blood, April 1, 2000; 95(7): 2397 - 2406.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ruiz-Velasco, M. Guerrero-Esteo, M. J. Briskin, and J. Teixido
The alpha 4 Integrin Subunit Tyr187 Has a Key Role in alpha 4beta 7-Dependent Cell Adhesion
J. Biol. Chem., March 15, 2000; 275(10): 7052 - 7059.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020